Underlying Differences in Health Spending Within the World Health Organisation Europe Region—Comparing EU15, EU Post-2004, CIS, EU Candidate, and CARINFONET Countries

Mihajlo (Michael) Jakovljevic, Paula Odete Fernandes, João Paulo Teixeira, Nemanja Rancic, Yuriy Timofeyev and Vladimir Reshetnikov
Additional contact information
Paula Odete Fernandes: UNIAG, Applied Management Research Unit, Instituto Politécnico de Bragança, 5300-253 Bragança, Portugal
João Paulo Teixeira: UNIAG, Applied Management Research Unit, Instituto Politécnico de Bragança, 5300-253 Bragança, Portugal
Nemanja Rancic: Faculty of Medicine, University of Defence, 11000 Belgrade, Serbia
Vladimir Reshetnikov: Department for Health Care and Public Health, Sechenov First Moscow State Medical University, Trubetskaya, 8, 119048 Moscow, Russia

IJERPH, 2019, vol. 16, issue 17, 1-15

Abstract: This study examined the differences in health spending within the World Health Organization (WHO) Europe region by comparing the EU15, the EU post-2004, CIS, EU Candidate and CARINFONET countries. The WHO European Region (53 countries) has been divided into the following sub-groups: EU15, EU post-2004, CIS, EU Candidate countries and CARINFONET countries. The study period, based on the availability of WHO Global Health expenditure data, was 1995 to 2014. EU15 countries have exhibited the strongest growth in total health spending both in nominal and purchasing power parity terms. The dynamics of CIS members’ private sector expenditure growth as a percentage of GDP change has exceeded that of other groups. Private sector expenditure on health as a percentage of total government expenditure, has steadily the highest percentage point share among CARINFONET countries. Furthermore, private households’ out-of-pocket payments on health as a percentage of total health expenditure, has been dominated by Central Asian republics for most of the period, although, for the period 2010 to 2014, the latter have tended to converge with those of CIS countries. Western EU15 nations have shown a serious growth of health expenditure far exceeding their pace of real economic growth in the long run. There is concerning growth of private health spending among the CIS and CARINFONET nations. It reflects growing citizen vulnerability in terms of questionable affordability of healthcare. Health care investment capability has grown most substantially in the Russian Federation, Turkey and Poland being the classical examples of emerging markets.

Keywords: health economics; WHO; Europe; public health expenditure; private health expenditure (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://www.mdpi.com/1660-4601/16/17/3043/pdf (application/pdf)
https://www.mdpi.com/1660-4601/16/17/3043/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:16:y:2019:i:17:p:3043-:d:259841

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().